On the effectiveness and costs of inhaled methoxyflurane versus usual analgesia for prehospital injury and trauma

Smith, Murray, Siriwardena, Niro, Spaight, Robert and Rowan, Elise (2021) On the effectiveness and costs of inhaled methoxyflurane versus usual analgesia for prehospital injury and trauma. In: 999EMS 2021, 23 March 2021, Virtual.

Full content URL: http://dx.doi.org/10.1136/emermed-2021-999.7

Documents
On the effectiveness and costs of inhaled methoxyflurane versus usual analgesia for prehospital injury and trauma

Request a copy
[img] PDF
999EMS abstract_MDSmith_revised.pdf - Abstract
Restricted to Repository staff only

158kB
Item Type:Conference or Workshop contribution (Presentation)
Item Status:Live Archive

Abstract

Background
Acute pain is often inadequately treated in adults with traumatic injury. Inhaled methoxyflurane, newly licensed in Europe for this indication, has limited evidence of clinical effectiveness in the prehospital setting. We aimed to investigate clinical effectiveness and costs of methoxyflurane administered by ambulance staff compared with usual analgesic practice (UAP) for patients with trauma.

Methods
We used a non-randomised control group pragmatic design comparing methoxyflurane versus Entonox® and parenteral analgesics. Verbal numerical pain scores (VNPS) were gathered over time in adults with moderate to severe trauma pain attended by ambulance staff trained in administering and supplied with methoxyflurane. Comparator VNPS were obtained from database records of UAP in similar patients. Clinical efficacy was tested using an Ordered Probit panel regression model of pain linked by observational rules to VNPS. Scenario analyses were used to compare durations under analgesia spent in severe pain, and costs.

Results
Over 12 months, 96 trained paramedics and technicians prepared 510 doses of methoxyflurane for administration to 483 patients. 32 patients reported side-effects, 19 of whom discontinued early. 13 patients, 10 aged over 75 years, were nonadherent to inhaler use instructions.
Modelling results showed statistically significant clinical effectiveness of methoxyflurane over each comparator (all p-values<0.001). Methoxyflurane’s time to achieve maximum pain relief was significantly faster (all p-values<0.001): 26.4 mins (95%CI 25.0-27.8) versus Entonox® 44.4 (39.5-49.3); 26.5 (25.0-27.9) versus IV morphine sulfate 41.8 (38.9-44.7); 26.5 (25.1-28.0) versus IV paracetamol 40.8 (34.7-46.9).
Scenario analyses of durations spent in severe pain were significantly less for methoxyflurane to comparators. Benefits of methoxyflurane were achieved at higher cost to comparators.

Conclusions
Methoxyflurane reduced pain more rapidly and to a greater extent than Entonox® and more quickly than parenteral analgesics in adults with moderate or severe pain due to trauma attended by ambulance clinicians. Methoxyflurane provides a useful addition to prehospital analgesia.

Keywords:Methoxyflurane
Subjects:L Social studies > L140 Econometrics
B Subjects allied to Medicine > B780 Paramedical Nursing
G Mathematical and Computer Sciences > G340 Statistical Modelling
Divisions:College of Social Science > School of Health & Social Care
ID Code:46779
Deposited On:05 Oct 2021 08:56

Repository Staff Only: item control page